Imatinib Terminated Phase 2 Trials for Cancer Brain / Cancers / Gastrointestinal Stromal Tumors / Tumors, Solid Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00180830Glivec Phase II Pediatric Study
NCT00091078Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
NCT00585221Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients